- Home
- EWBC vs EXEL Comparison
EWBC vs EXEL Comparison
Compare EWBC & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWBC
- EXEL
- Stock Information
- Founded
- EWBC 1998
- EXEL 1994
- Country
- EWBC United States
- EXEL United States
- Employees
- EWBC N/A
- EXEL N/A
- Industry
- EWBC Major Banks
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EWBC Finance
- EXEL Health Care
- Exchange
- EWBC Nasdaq
- EXEL Nasdaq
- Market Cap
- EWBC 11.8B
- EXEL 11.3B
- IPO Year
- EWBC 1999
- EXEL 2000
- Fundamental
- Price
- EWBC $108.63
- EXEL $44.29
- Analyst Decision
- EWBC Buy
- EXEL Buy
- Analyst Count
- EWBC 14
- EXEL 18
- Target Price
- EWBC $106.64
- EXEL $43.00
- AVG Volume (30 Days)
- EWBC 822.3K
- EXEL 3.3M
- Earning Date
- EWBC 07-22-2025
- EXEL 08-05-2025
- Dividend Yield
- EWBC 2.25%
- EXEL N/A
- EPS Growth
- EWBC 5.55
- EXEL 237.58
- EPS
- EWBC 8.38
- EXEL 2.20
- Revenue
- EWBC $2,407,834,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- EWBC $4.88
- EXEL $9.37
- Revenue Next Year
- EWBC $5.44
- EXEL $11.05
- P/E Ratio
- EWBC $12.74
- EXEL $20.10
- Revenue Growth
- EWBC 2.99
- EXEL 24.49
- 52 Week Low
- EWBC $68.27
- EXEL $21.82
- 52 Week High
- EWBC $113.95
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- EWBC 77.39
- EXEL 58.31
- Support Level
- EWBC $100.45
- EXEL $43.32
- Resistance Level
- EWBC $100.10
- EXEL $44.48
- Average True Range (ATR)
- EWBC 2.38
- EXEL 1.55
- MACD
- EWBC 1.06
- EXEL 0.10
- Stochastic Oscillator
- EWBC 99.40
- EXEL 45.55
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.